Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

10.48
Delayed Data
As of Feb 11
 +0.03 / +0.29%
Today’s Change
10.00
Today|||52-Week Range
25.56
-29.38%
Year-to-Date
No recent news for Momenta Pharmaceuticals Inc.

Today’s Trading

Previous close10.45
Today’s open10.36
Day’s range10.00 - 10.69
Volume724,791
Average volume (3 months)753,179
Market cap$721.0M
Dividend yield--
Data as of 02/11/2016

Growth & Valuation

Earnings growth (last year)+10.33%
Earnings growth (this year)+51.30%
Earnings growth (next 5 years)--
Revenue growth (last year)+47.33%
P/E ratioNM
Price/Sales11.91
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
PACBPacific Biosciences ...+0.16+1.77%
RLYPRelypsa Inc+1.42+8.99%
AIMTAimmune Therapeutics...+0.49+3.17%
FPRXFive Prime Therapeut...-0.18-0.62%
Data as of 02/11/2016

Financials

Next reporting dateFebruary 18, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$52.3M
Annual profit (last year)-$98.6M
Net profit margin-188.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class II Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers